This study aims to evaluate the usefulness of hemostasis using radiofrequency ablation for track bleeding that has occurred after percutaneous biopsy of the liver.
Purpose: To evaluate the usefulness of hemostasis using radiofrequency ablation for track bleeding after percutaneous liver biopsy. Method: * Enroll patients who continue to bleed despite conservative treatment for track bleeding that has occurred after liver biopsy. * Radiofreqeuncy ablation: Under monitoring vital signs and controlling pain with intravenous agents, the electrode is inserted into the bleeding focus. The bleeding focus is ablated. * Hemostasis is evaluated by ultrasound (right after radiofrequency ablation), CT scan (after the radiofrequency ablation), and ultrasound (the day after radiofrequency ablation) * If hemostasis fails using radiofrequency ablation, transarterial hepatic embolization is performed immediately.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Under the ultrasound guidance, the electrode is inserted into the bleeding focus of the liver and the bleeding focus is ablated.
Samsung Medical Center
Seoul, South Korea
RECRUITINGhemostasis rate
success rate of hemostasis using radiofrequency ablation on CT taken after radiofrequency ablation
Time frame: immediately after radiofrequency ablation
complication rate
complication rate associated with radiofrequency ablation on CT taken after radiofrequency ablation
Time frame: immediately after radiofrequency ablation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.